A historic Orrington plant received a Notice of Violation from the Maine Department of Environmental Protections.

Mallinckrodt Pharmaceuticals is under a Notice of Violation by the Maine Department of Environmental Protection for failure to clean up contamination. The company’s manufacturing facility on the ...

The department charges that Mallinckrodt has done an insufficient job removing hazardous materials from its former plant and has attempted to dodge its legal responsibilities.

Ireland-based Mallinckrodt Pharmaceuticals and Endo Inc (OTCQX: NDOI) have agreed to combine in a stock and cash deal worth ...

Simply sign up to the Pharmaceuticals sector myFT Digest -- delivered directly to your inbox. Mallinckrodt Pharmaceuticals and Endo have agreed to combine in a nearly $7bn deal after the pair ...

Mallinckrodt and Endo said they will merge through a $6.7 billion cash and stock deal creating a combined company that will be intent on bouncing back from their troubled recent histories ...